![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Comparison of HIV-1 Intermittent Viremia for Two Drug (DTG+RPV) vs Three Drug Current Antiretroviral Therapy in the SWORD-1 and SWORD-2 Studies
|
|
|
Reported by Jules Levin
HIV Drug Therapy, Glasgow 2018, October 28-31, 2018, Glasgow
Ruolan Wang,1Mark Underwood,1Justin Koteff,1Kostas Angelis,2Brian Wynne,1Veerle Van Eygen,3Elizabeth Blair,1Lesley Kahl,4Tia Vincent,4Michael Aboud4
1ViiV Healthcare, Research Triangle Park, NC, USA; 2GlaxoSmithKline,Stockley Park West, UK; 3Janssen Pharmaceutica, Beerse, Belgium; 4ViiV Healthcare, Brentford, UK
![1102181](../images%20/110218/110218-3/1102181.gif)
![1102182](../images%20/110218/110218-3/1102182.gif)
![1102183](../images%20/110218/110218-3/1102183.gif)
![1102184](../images%20/110218/110218-3/1102184.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|